Aristotle Atlantic Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $13.4M | Buy |
|
|||||
|
2024
Q2 | $22.6M | Sell |
|
|||||
|
2024
Q1 | $27.8M | Sell |
|
|||||
|
2023
Q4 | $25.2M | Buy |
|
|||||
|
2023
Q3 | $18.7M | Sell |
|
|||||
|
2023
Q2 | $26M | Buy |
|
|||||
|
2023
Q1 | $19.3M | Buy |
|
|||||
|
2022
Q4 | $18.8M | Sell |
|
|||||
|
2022
Q3 | $13.3M | Buy |
|
|||||
|
2022
Q2 | $12.3M | Buy |
|
|||||
|
2022
Q1 | $20.7M | Buy |
|
|||||
|
2021
Q4 | $21.6M | Buy |
|
|||||
|
2021
Q3 | $21.9M | Buy |
|
|||||
|
2021
Q2 | $17M | Buy |
|
|||||
|
2021
Q1 | $14.3M | Buy |
|
|||||
|
2020
Q4 | $14.7M | Buy |
|
|||||
|
2020
Q3 | $16M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Buy |
|
|||||
|
2020
Q1 | $7.69M | Buy |
|